Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Stjepko Pleština

13329

Stjepko

Pleština

dr. sc.

Naziv Uloga Akcije
Molekularni biljezi u solidnim tumorima - prediktivni i prognostički značaj voditelj
Biomedicinsko oslikavanje karcinoma dojke suradnik
Naziv Akcije
Bišof, Vesna ; Soče, Maja ; Vidović, Marina ; Viculin, Jelena ; Vrdoljak, Eduard ; Pleština, Stjepko REAL WORLD SURVIVAL OUTCOMES IN ADVANCED GASTRIC AND ESOPHAGOGASTRIC ADENOCARCINOMA – A RETROSPECTIVE ANALYSIS FROM UNIVERSITY HOSPITAL CENTRES ZAGREB AND SPLIT // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 78-79
Lešnjaković, Lucija ; Ganoci, Lana ; Bilić, Ivan ; Šimičević, Livija ; Mucalo, Iva ; Pleština, Stjepko ; Božina, Nada DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? // Pharmacogenomics, 24 (2023), 0135, 14. doi: 10.2217/pgs-2022-0135
Adžić, Gordan; Prejac, Juraj; Pleština, Stjepko Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report // Frontiers in oncology, XIII (2023), 01-04. doi: 10.3389/fonc.2023.1260989
Prejac, Juraj; Omrčen, Tomislav; Radić, Jasna; Vrdoljak, Eduard; Frobe, Ana; Pleština, Stjepko Predicting Trifluridine/Tipiracil Treatment in Refractory Metastatic Colorectal Cancer Patients: A Multicenter Exploratory Analysis // Oncology, (2023), doi: 10.1159/000533567
Budisavljević, Anuška ; Kelemenić-Dražin, Renata ; Silovski, Tajana ; Stjepko, Pleština ; Dedić Plavetić, Natalija Correlation between psychological resilience and burnout syndrome in oncologists amid the Covid-19 pandemic // Supportive care in cancer, Volume 31 (2023), Issue 4; 207, 9. doi: 10.1007/s00520-023-07660-3
Dedic Plavetic, Natalija ; Čular, Katarina ; Križić, Marija ; Popovic, Marina ; Plestina, Stjepko ; Silovski, Tajana Clinical characteristics and outcome of PIK3CA mutated hormone receptor positive (HR+), human epidermal growth factor 2 negative (HER2-), advanced breast cancer (BC) treated with cyclin- dependent kinase 4/6 inhibitors (CDK4/6i): Real world data. // Journal of clinical oncology. 2023. doi: 10.1200/JCO.2023.41.16_suppl.e13078
Golčić, Marin ; Simetić, Luka ; Herceg, Davorin ; Blažičević, Krešimir ; Kenđel Jovanović, Gordana ; Dražić, Ivan ; Belančić, Andrej ; Skočibušić, Nataša ; Palčevski, Dora ; Rubinić, Igor et al. Analysis of the Gut Microbiome and Dietary Habits in Metastatic Melanoma Patients with a Complete and Sustained Response to Immunotherapy // Cancers, 15 (2023), 11; 103390, 17. doi: 10.3390/cancers15113052
Božina, Nada ; Bilić, Ivan ; Ganoci, Lana ; Šimičević, Livija ; Pleština, Stjepko ; Lešnjaković, Lucija ; Trkulja, Vladimir DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine-based protocols // British journal of clinical pharmacology, 88 (2022), 5; 2190-2202. doi: 10.1111/bcp.15144
Gojević, Ante ; Knežević Stromar, Ivana ; Orešković, Ivana ; Premužić, Marina ; Čuković Čavka, Silvija ; Sirotković-Skerlev, Maja ; Dedić Plavetić, Natalija ; Sedlić, Filip ; Vranić, Melita ; Ostojić, Rajko et al. Interleukin-17 as a Marker of Inflammation and Fibrosis in Liver. 2022. str. 19-19
Kulić, Ana ; Gojević, Ante ; Knežević Stromar, Ivana ; Orešković, Ivana ; Premužić, Marina ; Čuković Čavka, Silvija ; Sirotković-Skerlev, Maja ; Dedić Plavetić, Natalija ; Sedlić, Filip ; Vranić, Melita et al. Anti-p53 protutijela u bolestima jetre // Biochemia Medica. 2022. str. 163-163
nije evidentirano
nije evidentirano